未來股份(600532.SH):上海未琨擬收購北京善方醫院不低於51%股權
格隆匯12月6日丨未來股份(600532.SH)發佈,公司全資子公司上海未琨醫院管理有限公司(“上海未琨”)與海隆投資及張軍於2021年12月6日簽署了《股權收購框架協議》,上海未琨擬自行或指定其關聯方以現金支付方式,通過從北京華實海隆石油投資有限公司(“海隆投資”)以及張軍處受讓部分北京善方醫院有限公司(“標的公司”)股權及對標的公司增資方式合計取得標的公司不低於51%股權,形成對標的公司的控制權。具體的股權轉讓比例和增資比例及款項支付待簽署正式收購協議時確定。
標的公司是一家坐落於北京市三環內的綜合醫療機構,醫院地理位置優越,交通便捷,標的公司擁有綜合臨牀科室、特色專科與亞專科。本次收購符合公司的戰略發展方向,有助於加快公司業務轉型,為公司在醫療服務行業進一步發展奠定良好基礎;有助於進一步提升上市公司的綜合競爭能力和後續發展能力,增強上市公司的抗風險能力和持續經營能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.